Ludwig Cancer Research scientists to present advances in immunotherapy, cancer metabolism

APRIL 10, 2021, NEW YORK – Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the April 9-14 American Association for Cancer Research (AACR) Annual Meeting, the first of two meetings which will be held online this year.

“The AACR Annual Meeting has long served as major opportunity for cancer researchers at all stages of their careers and from all over the world to meet, exchange ideas and forge collaborations to advance the study and treatment of cancer,” said Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research and Editor-in-Chief of AACR’s Cancer Research journal. “The COVID-19 pandemic may have disrupted the physical gathering, but the intellectual exchange it enables will continue unimpeded. Ludwig and its scientists are excited about participating in that exchange.”

Ludwig-affiliated researchers from the U.S. and Europe will present exciting discoveries in a wide variety of fields, including cancer metabolism, cancer genomics, tumor immunology and immunotherapy and cancer diagnostics, drug resistance and prevention.

Click here for a full list of Ludwig presentations and posters at the April 9-14 AACR meeting.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.